Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-2-9
pubmed:abstractText
The chemokine receptor CCR7 and its ligands regulate migration and colocalization of T cells and mature dendritic cells to and within secondary lymphoid organs. The requirement of CCR7 in efficient priming of allospecific cytotoxic CD8(+) T cells is poorly characterized. Here, we demonstrate a role for CCR7 in the initiation of an alloimmune response and in the development of transplant rejection. Remarkably, in a model of acute allogeneic tumor rejection, CCR7(-/-) mice completely failed to reject subcutaneously injected MHC class I mismatched tumor cells and cytotoxic activity of allospecific T cells was severely compromised. When solid tumors derived from wild-type mice were transplanted, recipient CCR7(-/-) mice were capable of rejecting the allografts. In contrast, tumor allografts transplanted from CCR7(-/-) donors onto CCR7(-/-) recipients showed allograft survival up to 28 days, suggesting a critical function of CCR7 on donor-type passenger leukocytes in the initiation of cytotoxic CD8(+) T cell responses. In a heterotopic heart transplantation model CCR7 deficiency resulted in significantly prolonged but not indefinite allograft survival. Additional prolongation of graft survival was observed when hearts from CCR7(-/-) mice were used as donor organs. Our results define a key role for CCR7 in allogeneic T cell priming within the context of draining lymph nodes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0014-2980
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
461-70
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:14768051-Adoptive Transfer, pubmed-meshheading:14768051-Animals, pubmed-meshheading:14768051-Antibodies, Neoplasm, pubmed-meshheading:14768051-Cytotoxicity Tests, Immunologic, pubmed-meshheading:14768051-Flow Cytometry, pubmed-meshheading:14768051-Graft Rejection, pubmed-meshheading:14768051-Graft Survival, pubmed-meshheading:14768051-Heart Transplantation, pubmed-meshheading:14768051-Histocompatibility Antigens Class I, pubmed-meshheading:14768051-Lymph Nodes, pubmed-meshheading:14768051-Lymphocyte Activation, pubmed-meshheading:14768051-Male, pubmed-meshheading:14768051-Mice, pubmed-meshheading:14768051-Mice, Inbred BALB C, pubmed-meshheading:14768051-Mice, Inbred C57BL, pubmed-meshheading:14768051-Mice, Knockout, pubmed-meshheading:14768051-Receptors, CCR7, pubmed-meshheading:14768051-Receptors, Chemokine, pubmed-meshheading:14768051-Survival Analysis, pubmed-meshheading:14768051-T-Lymphocytes, Cytotoxic
pubmed:year
2004
pubmed:articleTitle
The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
pubmed:affiliation
Department of Tumor Genetics and Immunogenetics, Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany. uhoepken@mdc-berlin.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't